APA (7th ed.) Citation

Aggarwal, R., Umetsu, S., Dhawan, M., Grabowsky, J., Carnevale, J., Howell, M., . . . Collisson, E. (2021). 512O Interim results from a phase II study of the ATR inhibitor ceralasertib in ARID1A-deficient and ARID1A-intact advanced solid tumor malignancies. Annals of Oncology, 32, S583. https://doi.org/10.1016/j.annonc.2021.08.1034

Chicago Style (17th ed.) Citation

Aggarwal, R., et al. "512O Interim Results from a Phase II Study of the ATR Inhibitor Ceralasertib in ARID1A-deficient and ARID1A-intact Advanced Solid Tumor Malignancies." Annals of Oncology 32 (2021): S583. https://doi.org/10.1016/j.annonc.2021.08.1034.

MLA (9th ed.) Citation

Aggarwal, R., et al. "512O Interim Results from a Phase II Study of the ATR Inhibitor Ceralasertib in ARID1A-deficient and ARID1A-intact Advanced Solid Tumor Malignancies." Annals of Oncology, vol. 32, 2021, p. S583, https://doi.org/10.1016/j.annonc.2021.08.1034.